<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001634'>Mitral valve prolapse</z:hpo> has a prevalence of 2% to 3% in the general population, with adverse outcomes such as <z:hpo ids='HP_0001653'>mitral valve regurgitation</z:hpo> (MVR), <z:hpo ids='HP_0001635'>heart failure</z:hpo>, and <z:hpo ids='HP_0100584'>endocarditis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Predictors of outcomes are used in idiopathic <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> for the timing of surgery, but such predictors are unknown in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, a population-based cohort study of 112 patients (49 male, 63 female; mean age 34 ± 15 years) with classic <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> with moderate or less MVR at baseline was conducted </plain></SENT>
<SENT sid="3" pm="."><plain>During 4.6 ± 3.6 years of follow-up, progression of MVR was observed in 41 patients and valve-related events, which comprised mitral valve <z:hpo ids='HP_0100584'>endocarditis</z:hpo> (7 events), <z:hpo ids='HP_0001635'>heart failure</z:hpo> (5 events), and mitral valve surgery (25 events), were observed in 31 patients </plain></SENT>
<SENT sid="4" pm="."><plain>Multivariate Cox proportional-hazards regression analysis identified a flail mitral leaflet (hazard ratio [HR] 3.262, 95% confidence interval [CI] 1.406 to 7.566, p = 0.006) and increased indexed end-systolic left ventricular diameters (HR 1.113, 95% CI 1.043 to 1.188, p = 0.001) as independent predictors of progression of MVR </plain></SENT>
<SENT sid="5" pm="."><plain>Similarly, mitral valve-related events were independently predicted by a flail mitral leaflet (HR 5.343, 95% CI 2.229 to 12.808, p &lt;0.001), and mild (HR 14.336, 95% CI 1.873 to 109.755, p = 0.01) or moderate (HR 16.849, 95% CI 2.205 to 128.76, p = 0.006) degree of MVR </plain></SENT>
<SENT sid="6" pm="."><plain>Conversely, <z:hpo ids='HP_0001724'>aortic dilatation</z:hpo>, <z:hpo ids='HP_0100775'>dural ectasia</z:hpo>, and <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:hpo ids='HP_0000005'>mode of inheritance</z:hpo> were not associated with outcome </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, the same clinical determinants that predict outcomes in idiopathic <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> also predict outcomes in <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> associated with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
</text></document>